Copyright Reports & Markets. All rights reserved.

Global Acne Vulgaris Treatment Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Acne Vulgaris Treatment Market Overview

      • 1.1 Product Overview and Scope of Acne Vulgaris Treatment
      • 1.2 Acne Vulgaris Treatment Segment by Type
        • 1.2.1 Global Acne Vulgaris Treatment Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 CB-0601
        • 1.2.3 CJM-112
        • 1.2.4 CLS-007
        • 1.2.5 Dapsone
        • 1.2.6 DFD-10
        • 1.2.7 DLX-2323
        • 1.2.8 Others
      • 1.3 Acne Vulgaris Treatment Segment by Application
        • 1.3.1 Acne Vulgaris Treatment Consumption Comparison by Application (2014-2025)
        • 1.3.2 Clinic
        • 1.3.3 Hospital
        • 1.3.4 Others
      • 1.3 Global Acne Vulgaris Treatment Market by Region
        • 1.3.1 Global Acne Vulgaris Treatment Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Acne Vulgaris Treatment Market Size
        • 1.4.1 Global Acne Vulgaris Treatment Revenue (2014-2025)
        • 1.4.2 Global Acne Vulgaris Treatment Production (2014-2025)

      2 Global Acne Vulgaris Treatment Market Competition by Manufacturers

      • 2.1 Global Acne Vulgaris Treatment Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Acne Vulgaris Treatment Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Acne Vulgaris Treatment Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Acne Vulgaris Treatment Production Sites, Area Served, Product Types
      • 2.5 Acne Vulgaris Treatment Market Competitive Situation and Trends
        • 2.5.1 Acne Vulgaris Treatment Market Concentration Rate
        • 2.5.2 Acne Vulgaris Treatment Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Acne Vulgaris Treatment Production Market Share by Regions

      • 3.1 Global Acne Vulgaris Treatment Production Market Share by Regions
      • 3.2 Global Acne Vulgaris Treatment Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Acne Vulgaris Treatment Production
        • 3.4.1 North America Acne Vulgaris Treatment Production Growth Rate (2014-2019)
        • 3.4.2 North America Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Acne Vulgaris Treatment Production
        • 3.5.1 Europe Acne Vulgaris Treatment Production Growth Rate (2014-2019)
        • 3.5.2 Europe Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Acne Vulgaris Treatment Production (2014-2019)
        • 3.6.1 China Acne Vulgaris Treatment Production Growth Rate (2014-2019)
        • 3.6.2 China Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Acne Vulgaris Treatment Production (2014-2019)
        • 3.7.1 Japan Acne Vulgaris Treatment Production Growth Rate (2014-2019)
        • 3.7.2 Japan Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Acne Vulgaris Treatment Consumption by Regions

      • 4.1 Global Acne Vulgaris Treatment Consumption by Regions
      • 4.2 North America Acne Vulgaris Treatment Consumption (2014-2019)
      • 4.3 Europe Acne Vulgaris Treatment Consumption (2014-2019)
      • 4.4 China Acne Vulgaris Treatment Consumption (2014-2019)
      • 4.5 Japan Acne Vulgaris Treatment Consumption (2014-2019)

      5 Global Acne Vulgaris Treatment Production, Revenue, Price Trend by Type

      • 5.1 Global Acne Vulgaris Treatment Production Market Share by Type (2014-2019)
      • 5.2 Global Acne Vulgaris Treatment Revenue Market Share by Type (2014-2019)
      • 5.3 Global Acne Vulgaris Treatment Price by Type (2014-2019)
      • 5.4 Global Acne Vulgaris Treatment Production Growth by Type (2014-2019)

      6 Global Acne Vulgaris Treatment Market Analysis by Applications

      • 6.1 Global Acne Vulgaris Treatment Consumption Market Share by Application (2014-2019)
      • 6.2 Global Acne Vulgaris Treatment Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Acne Vulgaris Treatment Business

      • 7.1 Common Pharma Inc
        • 7.1.1 Common Pharma Inc Acne Vulgaris Treatment Production Sites and Area Served
        • 7.1.2 Acne Vulgaris Treatment Product Introduction, Application and Specification
        • 7.1.3 Common Pharma Inc Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Cutanea Life Sciences Inc
        • 7.2.1 Cutanea Life Sciences Inc Acne Vulgaris Treatment Production Sites and Area Served
        • 7.2.2 Acne Vulgaris Treatment Product Introduction, Application and Specification
        • 7.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Dermira Inc
        • 7.3.1 Dermira Inc Acne Vulgaris Treatment Production Sites and Area Served
        • 7.3.2 Acne Vulgaris Treatment Product Introduction, Application and Specification
        • 7.3.3 Dermira Inc Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 ELORAC Inc
        • 7.4.1 ELORAC Inc Acne Vulgaris Treatment Production Sites and Area Served
        • 7.4.2 Acne Vulgaris Treatment Product Introduction, Application and Specification
        • 7.4.3 ELORAC Inc Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Ensol Biosciences Inc
        • 7.5.1 Ensol Biosciences Inc Acne Vulgaris Treatment Production Sites and Area Served
        • 7.5.2 Acne Vulgaris Treatment Product Introduction, Application and Specification
        • 7.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Foamix Pharmaceuticals Ltd
        • 7.6.1 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Production Sites and Area Served
        • 7.6.2 Acne Vulgaris Treatment Product Introduction, Application and Specification
        • 7.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Galderma SA
        • 7.7.1 Galderma SA Acne Vulgaris Treatment Production Sites and Area Served
        • 7.7.2 Acne Vulgaris Treatment Product Introduction, Application and Specification
        • 7.7.3 Galderma SA Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 GlaxoSmithKline Plc
        • 7.8.1 GlaxoSmithKline Plc Acne Vulgaris Treatment Production Sites and Area Served
        • 7.8.2 Acne Vulgaris Treatment Product Introduction, Application and Specification
        • 7.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Helix BioMedix Inc
        • 7.9.1 Helix BioMedix Inc Acne Vulgaris Treatment Production Sites and Area Served
        • 7.9.2 Acne Vulgaris Treatment Product Introduction, Application and Specification
        • 7.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Hovione FarmaCiencia SA
        • 7.10.1 Hovione FarmaCiencia SA Acne Vulgaris Treatment Production Sites and Area Served
        • 7.10.2 Acne Vulgaris Treatment Product Introduction, Application and Specification
        • 7.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Lee's Pharmaceutical Holdings Ltd
      • 7.12 LEO Pharma A/S
      • 7.13 Novabiotics Ltd
      • 7.14 Novan Inc
      • 7.15 Novartis AG
      • 7.16 Paratek Pharmaceuticals Inc
      • 7.17 Pfizer Inc
      • 7.18 Phosphagenics Ltd

      8 Acne Vulgaris Treatment Manufacturing Cost Analysis

      • 8.1 Acne Vulgaris Treatment Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Acne Vulgaris Treatment
      • 8.4 Acne Vulgaris Treatment Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Acne Vulgaris Treatment Distributors List
      • 9.3 Acne Vulgaris Treatment Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Acne Vulgaris Treatment Market Forecast

      • 11.1 Global Acne Vulgaris Treatment Production, Revenue Forecast
        • 11.1.1 Global Acne Vulgaris Treatment Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Acne Vulgaris Treatment Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Acne Vulgaris Treatment Price and Trend Forecast (2019-2025)
      • 11.2 Global Acne Vulgaris Treatment Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Acne Vulgaris Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Acne Vulgaris Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Acne Vulgaris Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Acne Vulgaris Treatment Production, Revenue Forecast (2019-2025)
      • 11.3 Global Acne Vulgaris Treatment Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Acne Vulgaris Treatment Consumption Forecast (2019-2025)
        • 11.3.2 Europe Acne Vulgaris Treatment Consumption Forecast (2019-2025)
        • 11.3.3 China Acne Vulgaris Treatment Consumption Forecast (2019-2025)
        • 11.3.4 Japan Acne Vulgaris Treatment Consumption Forecast (2019-2025)
      • 11.4 Global Acne Vulgaris Treatment Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Acne Vulgaris Treatment Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Acne Vulgaris Treatment market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Acne Vulgaris Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acne Vulgaris Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Common Pharma Inc
        Cutanea Life Sciences Inc
        Dermira Inc
        ELORAC Inc
        Ensol Biosciences Inc
        Foamix Pharmaceuticals Ltd
        Galderma SA
        GlaxoSmithKline Plc
        Helix BioMedix Inc
        Hovione FarmaCiencia SA
        Lee's Pharmaceutical Holdings Ltd
        LEO Pharma A/S
        Novabiotics Ltd
        Novan Inc
        Novartis AG
        Paratek Pharmaceuticals Inc
        Pfizer Inc
        Phosphagenics Ltd

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        CB-0601
        CJM-112
        CLS-007
        Dapsone
        DFD-10
        DLX-2323
        Others

        Segment by Application
        Clinic
        Hospital
        Others

        Buy now